Ionis Pharmaceuticals (IONS) Interest Coverage Ratio Growth (3y) (2012 - 2026)
Powered by 
Analysis
Ionis Pharmaceuticals (IONS) Interest Coverage Ratio Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 29.79% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -44.22% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 33.30% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -35.50% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 81.16% |
| 10 | Ionis Pharmaceuticals | 9.60 Bn | 7.55 Bn | 265.21 Mn | 17.44% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.44% |
| Mar 31, 2026 | 31.56% |
| Dec 31, 2025 | 28.23% |
| Sep 30, 2025 | -11.20% |
| Jun 30, 2025 | 41.72% |
| Mar 31, 2025 | -9.67% |
| Dec 31, 2024 | -31.39% |
| Sep 30, 2024 | 0.88% |
| Jun 30, 2024 | 21.95% |
| Mar 31, 2024 | 1.85% |
| Dec 31, 2023 | 47.56% |
| Sep 30, 2023 | -31.33% |
| Jun 30, 2023 | -22.91% |
| Mar 31, 2023 | -36.85% |
| Dec 31, 2022 | -119.58% |
| Sep 30, 2022 | -411.16% |
| Jun 30, 2022 | -193.05% |
| Mar 31, 2022 | -66.14% |
| Dec 31, 2021 | 371.38% |
| Sep 30, 2021 | -181.42% |